Formycon AG will develop, register, manufacture and supply the product, while Zydus Lifesciences Global FZE, United Arab Emirates will be responsible for the commercialization of FYB206 in the defined territories
The new site marks the company’s first operation in the region
Adverse events were similar to placebo, and no AP-101-induced antibody responses were detected
Captured microbes are then neutralized on engineered microbicidal surfaces
76 of 180 long COVID-associated genes also linked to ME
Biocon will acquire the residual stake held by Mylan (Viatris) for a total consideration of US$ 815 million
Peapod Bio’s proprietary technologies can efficiently identify inhibitors and binding molecules for virtually any target
Terray and BMS aim to accelerate small molecule drug discovery by harnessing EMMI’s integrated experimental and AI capabilities
Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
Grant of Permission to manufacture and market FDC of Naproxen Delayed Release and Esomeprazole capsule (375mg/500mg + 20mg/20mg)
Subscribe To Our Newsletter & Stay Updated
